The Effects of Pregabalin on Postoperative Pain After Cardiac Surgery

NCT ID: NCT01701921

Last Updated: 2016-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether pregabalin is effective in the treatment of acute postoperative pain after cardiac surgery if administered before the surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pregabalin was introduced as an antiepileptic drug with analgesic anti-hyperalgesic and anxiolytic properties and was also used to treat neuropathic pain. In recent years it has been used as part of a multimodal management of acute postoperative pain after various types of surgery. We study the effect of pregabalin administered before cardiac surgery on acute and chronic postoperative pain. Post CABG syndrome is well known since 1980 and various analgesic methods have been used from time to time (opioids, regional analgesia, non-steroidal anti-inflammatory drugs). In our research patients will be divided into three groups. The control group will receive a placebo capsule before surgery. The second group will receive 75mg of pregabalin per os before surgery while the third will receive 150mg of pregabalin. After the surgery all patients will be connected to an intravenous PCA morphine pump for 48 hours. The postoperative pain will be assessed with the Visual Analogue Scale (0-10) every day. Total morphine consumption by the patients as well as any other pain medications administered supplementary will be registered and compared between the different groups. Remaining postoperative pain will be assessed after 3 months. The results will be statistically analyzed in order to determine whether there is significant difference in pain management between the groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregabalin 75

Pregabalin 75mg by mouth one hour before surgery

Group Type EXPERIMENTAL

Pregabalin 75mg

Intervention Type DRUG

Pregabalin 75mg by mouth one hour before surgery

Pregabalin 150

Pregabalin 150mg by mouth one hour before surgery

Group Type ACTIVE_COMPARATOR

pregabalin 150 mg

Intervention Type DRUG

pregabalin 150mg by mouth one hour before surgery

Sugar pill

Placebo : Sugar pill manufactured to mimic pregabalin capsule by mouth one hour before surgery

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Sugar pill designed to mimic pregabalin capsule, by mouth one hour before surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pregabalin 75mg

Pregabalin 75mg by mouth one hour before surgery

Intervention Type DRUG

pregabalin 150 mg

pregabalin 150mg by mouth one hour before surgery

Intervention Type DRUG

Placebo

Sugar pill designed to mimic pregabalin capsule, by mouth one hour before surgery

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lyrica Lyrica Sugar pill

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients' age 18-85years who are undergoing cardiac surgery

Exclusion Criteria

* Chronic pain syndromes
* Renal failure
* Age \>85
* Allergy to Pregabalin
* Patients already taking pregabalin
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Larissa University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aikaterini Bouzia

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aikaterini A Bouzia, Medicine

Role: PRINCIPAL_INVESTIGATOR

PhD candidate, School of Medicine, Univercity of Larissa

Georgios Vretzakis, Medicine

Role: STUDY_DIRECTOR

Associate Professor of Anaesthesiology, Schooll of Medicine, University of Larissa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Univercity Hospital of Larissa

Larissa, Thessaly, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7/13-07-2011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.